04Sep 2022
Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus‐related squamous cell cancer: Long‐term results

Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus‐related squamous cell cancer: Long‐term results

To report the long‐term oncological and functional outcomes of en bloc TORS lateral oropharyngectomy to address the close/involved margin following diagnostic tonsillectomy in HPV‐related SCC of unknown primary. TORS specimens did not evidence residual carcinoma in 93% of patients. Long‐term oncological outcomes confirm TORS lateral oropharyngectomy alone is an oncologically safe treatment. Therefore, this approach is warranted due consideration to mitigating the morbidity of adjuvant radiotherapy treatment in this group of patients.

  • #ent

Like

Save

Share